Corcept Therapeutics Incorporated (CORT)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 106,140 | 101,418 | 112,512 | 106,011 | 94,181 |
| Revenue | US$ in thousands | 482,375 | 401,858 | 365,978 | 353,874 | 306,486 |
| Net profit margin | 22.00% | 25.24% | 30.74% | 29.96% | 30.73% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $106,140K ÷ $482,375K
= 22.00%
Corcept Therapeutics Inc's net profit margin has displayed a generally stable trend over the past five years, ranging from a high of 30.74% in 2021 to a low of 22.00% in 2023. The company's ability to convert its revenues into profits has fluctuated over this period but has largely remained relatively strong, staying above 20% each year. It is noteworthy that the net profit margin saw a slight decline in recent years from the peak in 2021. This may indicate factors such as changes in expenses, pricing strategies, or revenue generation that impacted the company's profitability. Overall, despite some fluctuations, Corcept Therapeutics Inc has maintained a healthy level of net profit margin, suggesting efficient cost management and profitability relative to its revenue.
Peer comparison
Dec 31, 2023